Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The Vatican And The Cura Foundation Host The Fourth International Conference In An Effort To Unite To Cure

Created by the Pontifical Council for Culture and the Cura Foundation, This Historic 3-Day Event Gathers Global Influencers from Health Care, Medicine, Media, Entertainment, Technology, Government and Faith to Advance Human Health and Discuss the Impact New Technology Will Have on Society and Culture

Cura Foundation logo

News provided by

Cura Foundation

Apr 24, 2018, 07:00 ET

Share this article

Share toX

Share this article

Share toX

VATICAN CITY and NEW YORK, April 24, 2018 /PRNewswire/ -- The Vatican's Pontifical Council for Culture and the Cura Foundation announced the beginning of Unite to Cure: A Global Health Care Initiative, wherein leading journalists will moderate three days of historic discussions at the Aula Nuova del Sinodo in Vatican City (April 26-28).

The event, the fourth of its kind, seeks to raise global awareness and create a forum for collaboration around the wide array of powerful and promising cell therapies, gene therapies, and immunotherapies emerging from medical institutions around the world, as well as the impact new technology will have on humanity and society. The 2018 event will also examine the role of artificial intelligence, virtual reality and big data in health care delivery, and will discuss how technology can be used to extend health care access to less developed nations and to the underserved. Participants will also explore ways to prevent disease through behavior modifications, vaccinations, mediation and diet.

Highlights of the 2018 event include:

  • The Holy Father, Pope Francis, will meet with attendees in a scheduled private audience and offer an address.
  • Panels moderated by Dr. Sanjay Gupta, MD (CNN); Dr. Mehmet Öz, MD; Meredith Vieira; and Dr. Max Gomez, PhD (CBS New York).
  • Patients who have faced, or are facing, dangerous diseases and debilitating medical conditions will share their stories of hope and be honored as 'Pontifical Heroes.'
  • A Special Guest will participate in a panel with Bob Roth, discussing the impact meditation can have in both adults and children.
  • A World Golf Hall of Fame Member will discuss how stem cells improved his orthopedic ailments, relieving his back and shoulder pain.
  • Life and Business Strategist Tony Robbins will share his views on techniques to empower people and lower stress, as well as the impact people can have on one another by sharing their stories with others.

"This is one of the most powerful and inspirational global events — it's like Davos, but for health care," said Dr. Robin Smith, President of the Cura Foundation. "We are trying to educate the world and foster hope about the myriad life changing therapies and innovations in development that are driving today's health care revolution. Here in this intimate setting, we seek to break down the barriers and promote multidisciplinary collaboration, as well as encourage support and investment in research and innovation. We want influencers to do their part to grow healthy communities through prevention, education and better access to care. One of the hallmarks of the Vatican event is that we foster open, inclusive discussions about the many ethical, cultural and anthropological implications of emerging technologies, such as gene editing and CRISPR, as well as the transformative impact technology can have on many of the incurable and rare diseases affecting children."

The Conference Goals include:

  • Continuing the global Unite to Cure campaign to improve human health and creating a forum for collaboration to advance cures.
  • Uniting people without prejudice to stimulate an open dialogue and bring about an interdisciplinary approach to tackle major health care challenges around the globe.
  • Increasing awareness, educating the public on scientific advancements and inspiring the next generation.
  • Discussing the effect of emerging technologies and their anthropological, ethical, cultural, religious and societal implications.
  • Leading the conversation around personalized medicine, regenerative technologies, CRISPR and other innovations, and discussing their impacts on the environment, human health, culture and society.
  • Translating complex science into accessible language to catalyze the conversation.
  • Reducing the leading causes of cancer in our children, such as smoking, obesity and HPV.
  • Increasing the number of registrants in the Be The Match® bone marrow transplantation program, and improve diversity in registrants to enable more individuals in need to find a match.
  • Inspiring people to help one another and share their stories of hope.

"The human body holds unique capabilities, which must be understood and harnessed with extraordinary care," said His Eminence Cardinal Ravasi, President of the Pontifical Council for Culture. "We are living in extraordinary times, an era where cures are being developed for many diseases that cause suffering on a global scale. However, as these therapies are being introduced, we must stop and ask the important questions that underlie scientific discovery: 'What will be the societal and culture impact and even the possible anthropologic effects? Where should we draw the line?' This event provides the platform to discuss these questions and more."

Panel discussions at the 2018 event include:

  • "Global Approaches to a World Without Disease," featuring Gina Agiostratidou, PhD, The Helmsley Charitable Trust Type 1 Diabetes (T1D) Program; Ronald DePinho, MD, The University of Texas MD Anderson Cancer Center; Richard Derman, MD, MPH, Thomas Jefferson University; and Michael Farkouh, MD, University of Toronto.
  • "The Culture of Life and Religious Influence on Health," featuring Reverend Kevin FitzGerald, SJ, PhD, PhD, Georgetown University; Rabbi Edward Reichman, MD, Albert Einstein College of Medicine of Yeshiva University; and Elder Dale Renlund, MD, Member of the Quorum of the Twelve Apostles, The Church of Jesus Christ of Latter-day Saints.
  • "The Plant Food Revolution – Good for You and Good for the Environment," featuring Neal Barnard, MD, George Washington University School of Medicine and Health Sciences; Francesco Branca, MD, PhD, World Health Organization; Patrick Brown, MD, PhD, Impossible Foods and Stanford University School of Medicine; David Jenkins, DM, DPhil, DSc, University of Toronto; and Walter Willett, MD, DrPH, Harvard Medical School.
  • "Genetic Testing and Wellness," featuring Steve Herrmann, PhD, Sanford Research; and David Pearce, PhD, Sanford Health.
  • "Patient Advocacy and Bone Marrow Donation in the Age of Cell Therapy," featuring C. Randal Mills, PhD, National Bone Marrow Donor Program; and Bernard Siegel, JD, World Stem Cell Summit.
  • "Advancements in Treating Rare Diseases," featuring Sean Nolan, AveXis; Jill Weimer, PhD, Sanford Research; James Wilson, MD, PhD, University of Pennsylvania; Michael Yeaman, PhD, Harbor-UCLA Medical Center; and Frank Sasinowski, MPH, JD, Omega Center and Hyman, Phelps & McNamara.
  • "The Pharmacy of the Future – Cells Not Pills," featuring Eckhard Alt, MD, PhD, Founder, Isar Klinikum; Jason Hurd, MD, Sanford Orthopedics and Sports Medicine; Mark Lundeen, MD, Sanford Health; and a World Golf Hall of Fame Member.
  • "Stem Cells for Autoimmune Disease," featuring Richard Burt, MD, Northwestern University; "Clinical Experience Using Cell Therapy Derived from Placental Cells," featuring Robert Hariri, MD, PhD, Celularity; and "Novel Strategies for Biological Drug Development," with Marc S. Penn, MD, PhD, Black Beret Life Sciences.
  • "Longevity and the Morality of Extreme Life Extension," featuring Francis Collins, MD, PhD, 16th Director of the U.S. National Institutes of Health; Reverend Nicanor Pier Giorgio Austriaco, OP, PhD, STD, Providence College; George Church, PhD, Harvard Medical School and Massachusetts Institute of Technology; Peter Diamandis, MD, XPRIZE Foundation; Rabbi Edward Reichman, MD, Albert Einstein College of Medicine of Yeshiva University; and Elder Dale Renlund, MD, Member of the Quorum of the Twelve Apostles, The Church of Jesus Christ of Latter-day Saints.
  • "The Role of Virtual Reality, Implantable Devices and Emerging Technology in the Management of Disease," featuring Mike Muller, Arm; and David Rhew, MD, Samsung Electronics America; "Population Health Intelligence" with Deborah DiSanzo, IBM Watson Health; David B. Nash, MD, Jefferson College of Population Health, Thomas Jefferson University; and Glenn Pomerantz, MD, JD, Blue Cross and Blue Shield of Minnesota.
  • "Gene Editing and CRISPR," featuring Katrine Bosley, Editas Medicine; George Church, PhD, Harvard Medical School and Massachusetts Institute of Technology; Samarth Kulkarni, PhD, PhD, CRISPR Therapeutics; John Leonard, MD, Intellia Therapeutics; and Duanqing Pei, PhD, Chinese Academy of Sciences.
  • "The Promise and Peril of Human Cell and Gene Therapy Research," featuring Francis Collins, MD, PhD, 16th Director of the U.S. National Institutes of Health; and "Impacting Children's Health Through Meditation Globally," featuring Bob Roth, David Lynch Foundation, and Special Guest.
  • "Fake News and the Ethical Responsibilities of Media," featuring Max Gomez, PhD and Monsignor Dario Edoardo Viganò, Former Prefect and Assessor to Secretariat for Communications, Vatican.
  • "Prizes to Accelerate Innovation and Discovery," featuring Peter Diamandis, MD, XPRIZE Foundation; Micah Aberson, Sanford Health; and David Pearce, PhD, Sanford Health.
  • "10 Health Moonshots: How a Global Army of Health Transformers is Accomplishing One Impossible Dream," featuring Howard Krein, MD, PhD, StartUp Health, Thomas Jefferson University Hospital and Health Policy and Innovation, Sidney Kimmel Cancer Center; and Steven Krein, StartUp Health.

"Through this extraordinary event, and our partnership with the Cura Foundation, we seek to articulate a powerful and important perspective on the future of health care and drug development," said Monsignor Tomasz Trafny, Head of the Science and Faith Department at the Pontifical Council for Culture. "We hope to show the world that faith and science can co-exist and, in fact, feed on each other symbiotically, catalyzing hope, cures and as a mutual commitment to decrease human suffering."

Unite To Cure, The Fourth International Vatican Conference, is a continuation of a nine-year partnership collaboration between the Vatican's Pontifical Council for Culture, the Cura Foundation, the Stem For Life Foundation and STOQ (Science, Theology and the Ontological Quest).

To learn more about Unite To Cure, The Fourth International Vatican Conference, please visit: http://vaticanconference2018.com/. Follow us on Twitter @CuraFdn and on Facebook at facebook.com/TheCuraFoundation, and join the conversation with #UnitetoCure.

The Pontifical Council for Culture traces its origins to the Second Vatican Council and its opening up to that great, dynamic, worried and multiform world of contemporary culture. In its Pastoral Constitution Gaudium et Spes, the Council Fathers expressed the need for the Church to continually place itself before the needs of the cultures of the world. It was a new period of history where a new humanism was arising, and the Church, faithful to its own traditions, was aware of the universality of its mission, entering into communion with the different forms of culture, a communion that would enrich the Church as much as the cultures. The Pontifical Council for Culture is committed to the dialogue with many realities in their relation to culture and faith such Art, Music, Cultural Goods, Cultures in the World, Mysticism, Atheism, Economics, Language & Communication, International Cultural Bodies, Sport and Science. For more information, please visit: http://www.cultura.va

The Science and Faith Foundation (STOQ) is a Foundation under Vatican law promoted by the Pontifical Council for Culture. The identity and mission of the Foundation have their main Magisterial references in the Pastoral Constitution Gaudium et Spes, in the talks of St John Paul II and Benedict XVI on the relations between science and faith, particularly in the Encyclical Fides et Ratio. The Foundation aims to give continuity to the activities of Project STOQ, which emerged from the collaboration between the Pontifical Council for Culture and Pontifical Roman Universities following the Galileo Commission and the Jubilee of Scientists in the year 2000. Among the aims of the Foundation are research and study of the themes of dialogue between science, philosophy and theology; realization of conferences and other activities of high cultural and scientific value, even at the popular level; publication of works of merit on the main arguments of the science-faith dialogue. For more information, please visit: http://stoqfoundation.org/

The Cura Foundation leads a major global health movement with the passionate purpose to improve human health. Cura unites public and private sectors, partnering with doctors, patients, business leaders, philanthropists and thought leaders to collaborate and create breakthroughs around the world. The foundation drives change by raising awareness of scientific advancements in genomics, emerging technologies and big data to usher in the future of medicine. Cura helps people live longer, better lives free from suffering. The Cura Foundation is a nonsectarian, nonpartisan, public and tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. For more information, please visit: https://thecurafoundation.org/

The Stem For Life Foundation (SFLF) is the educational and advocacy subsidiary of The Cura Foundation and is devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions, as opposed to merely treating their symptoms. The Foundation stands at the forefront of a fundamental shift away from traditional drug treatment in favor of amplifying the body's natural repair mechanisms to vanquish disease. For more information, please visit: http://www.stemforlife.org

SOURCE Cura Foundation

Related Links

https://thecurafoundation.org/

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.